header logo image


Page 37«..1020..36373839..5060..»

Archive for the ‘Arthritis’ Category

Knee injuries in adults can lead to arthritis – The Straits Times

Sunday, February 16th, 2020

Young adults who have had knee injuries are much more likely than uninjured peers to develop arthritis in the knee by middle age, especially if they have broken bones or torn connective tissue, a study suggests.

Researchers followed almost 150,000 adults from ages 25 to 34, including about 5,200 with a history of knee injuries, for almost two decades.

Compared to people who never had knee injuries, those who did were nearly six times as likely to develop knee osteoarthritis during the first 11 years of follow-up, with more than triple the risk over the next eight years.

"Injuries that occur inside the knee joint, for example in the meniscus or cruciate ligament, may alter the biomechanical loading patterns in the knee," said study leader Barbara Snoeker, of Sweden's Lund University.

"Such injuries may lead to an imbalance in force transmissions inside the knee joint, consequently overloading the joint cartilage and leading to increased risk of developing osteoarthritis, compared to injuries that mainly affect the outside of the knee joint, such as contusions."

Osteoarthritis often affects the large weight-bearing joints and can eventually lead to the need for total joint replacement, the researchers noted in the British Journal of Sports Medicine.

Known risk factors include being overweight, older, female or having a job that puts a lot of stress on the joints, the study team note.

While a history of knee injuries is also a known risk factor, research to date has not offered a clear picture of whether certain types of injuries might be more likely to lead to osteoarthritis.

Two-thirds of the people in the study with knee injuries were male. After 19 years of follow-up, 422 people with knee injuries, or 11.3 per cent, developed knee osteoarthritis. So did 2,854, or 4 per cent, of people without knee injuries.

Most often, injuries involved multiple structures of the knee; this accounted for 21 per cent of participant knee injuries.

The second most common type of injury was cuts and contusions, at 18 per cent, followed by cartilage or other tissue tears at 17 per cent.

CRUCIATE LIGAMENT INJURIES

Damage to the tissue connecting the thighbone to the shinbone.

MENISCAL TEARS

Damage to cartilage connecting the same two bones.

FRACTURES OF THE SHINBONE

Where it meets the knee, or of the kneecap.

Cruciate-ligament injuries, or damage to the tissue connecting the thighbone to the shinbone, were associated with a 19.6 per cent greater risk of knee osteoarthritis, the study also found.

Meniscal tears, or damage to cartilage connecting the same two bones, were associated with a 10.5 per cent greater risk of osteoarthritis.

Fractures of the shinbone where it meets the knee, or of the kneecap, were associated with a 6.6 per cent greater risk.

Injuries involving multiple structures in the knee may have been under-reported, leading researchers to underestimate the risk associated with these types of injuries, said Jonas Bloch Thorlund, a professor of musculoskeletal health at the University of Southern Denmark, who was not involved in the study.

Another limitation is that researchers did not look at patient's body mass index (BMI), so they could not tell whether differences in weight might explain patients' risk of osteoarthritis, said Dr Kyle Hammond of the Emory Sports Medicine Centre in Atlanta.

What happens after knee injuries can also influence the risk of osteoarthritis down the line, said Hammond, who also was not involved in the study.

"Counselling a patient on how to safely and consistently return to a positive fitness programme ensures that they will maintain flexibility and strength, as well as keeping their weight at their ideal body weight," he said.

Rehabilitation matters, regardless of what other treatments patients receive, said Adam Culvenor, a sports and exercise medicine researcher at La Trobe University in Bundoora, Australia.

"Once these injuries occur, optimally managing them with an intense and progressive period of rehabilitation under the guidance of a physical therapist (irrespective of the decision to have surgery or not) to strengthen the muscles around the knee to facilitate a return to function and physical activity is likely to reduce the risk of osteoarthritis and persistent symptoms longer-term," Culvenor said by e-mail.

REUTERS

Visit link:
Knee injuries in adults can lead to arthritis - The Straits Times

Read More...

Former WABC-TV Eyewitness News Medical Reporter Joins New York Health – Long Island Weekly News

Sunday, February 16th, 2020

Millions of residents in the tristate area recognize Dr. Jay B. Adlersberg from his longtime position as the medical correspondent for WABC-TVs Eyewitness News. For 30 years, hes reported nightly on advances in the art and science of medicine. As an award-winning journalist and renowned rheumatologist and internist, Adlersberg provided his audience with well-explained insight on how scientific research relates to patients.

Now, Adlersberg is bringing that same commitment to patient care to New York Health.NY Health is a new, but rapidly growing network of independent board certified physicians with facilities in Manhattan, Queens, the Bronx, Nassau County and Suffolk County. Its specialties range from nephrology to urology, complemented with physical therapy. Through its parent company, New York Cancer Blood, NY Health has robust infusion centers that not only allow for advanced cancer treatments, but also allow Adlersberg to treat rheumatology patients in one place in less time.

Adlersberg, who has 45 years of experience treating the most severe forms of arthritis and joint disease, often employs intravenously-administered biologic medications like Humira to help patients achieve remission for debilitating conditions like rheumatoid arthritis. These drugs cannot be taken orally, and require patients to go to infusion centers for treatment. Prior to joining NY Health, Adlersberg would have to send patients to facilities outside his office to receive these life-changing infusions.

Joining NY Health was a no-brainer for me, Adlersberg said. Previously, I was sending patients to a different place for these infusions and if someone had a reaction to the drug, I couldnt see it. I would have to depend on nurses to describe it to me because I couldnt get to the place of infusion. Now, I have an office that is 40 feet away from the infusion center. If someone does have a reaction, I can walk right over and look and talk to the patient. That is the way I want to practice medicine, now I have a hand in everything that happens.

Dr. Jay Adlersberg

Adlersbergs new position at NY Health allows for a better, more personalized patient experience. Patients can now receive their infusions in one place in less than 90 minutes.

Previously, it would take three hours, Adlerberg said. They would have to sign in, and sign in a second time. It was a lot more paperwork and a lot more time consuming. Now, they can do it on a lunch hour if they wanted to. They will save so much time.

Adlersberg, brings a robust resume to NY Health. Aside from his award-winning reporting for WABC-TVs Eyewitness News, Adlersberg serves on the board of the New York chapter of the Arthritis Foundation. Educated at the University of Pittsburgh, where he graduated junior year Phi Beta Kappa and magna cum laude, he went on to graduate from the University of Pennsylvania School of Medicine, the nations oldest medical school and one of its most prestigious.

He completed a coveted residency at the countrys most respected city hospital and training ground for clinical medicine, the Bellevue Hospital Center of NYU Langone Medical Center. Adlersberg did his fellowship in rheumatology and immunology as an NIH-Postdoctoral Fellow at the Irvington House Institute of NYU Medical Center under the guidance of the late Dr. Edward C. Franklin, a world-renowned immunologist and member of the National Academy of Sciences.

Adlersberg, whose main interests are rheumatoid arthritis, the arthritis of psoriasis, back pain and autoimmune disorders, has been a forefront of intravenously administering biologic medications to treat his patient for two decades.

These drugs dont just treat the disease, Adlersberg said. They can essentially make it go away. I have been using them to treat patients for 20 years. One woman went from gaining 30 pounds because she couldnt go to the gym since her knees and ankles were so swollen and painful to going back to wearing high heels after four months of treatment.

Dr. Rohit Reejsinghani, executive director of NY Health, said the addition of Adlersberg is part of NY Healths commitment to creating a patient-centric model of care, through better connecting patients with their doctors for more personalized attention.

Dr. Adlersberg is one of the most respected rheumatologists in the country, Reejsinghani said. He invented the infusion game and because of that I said we need to have him on board. Our infusions centers are built within our cancer offices so having Dr. Adlersberg allows us to treat a different patient population within these state-of-the-art infusion centers. Bringing him on board will bring NY Health to the next frontier.

The rest is here:
Former WABC-TV Eyewitness News Medical Reporter Joins New York Health - Long Island Weekly News

Read More...

Paddy McGuinness health: Top Gear presenters shock diagnosis at the age of 44 – Express

Sunday, February 16th, 2020

Osteoarthritis and rheumatoid arthritis are the two most common types of arthritis.

Osteoarthritis is the most common type of arthritis in the UK, affecting nearly nine million people.

It most often develops in adults who are in their mid-40s or older. It's also more common in women and people with a family history of the condition.

But it can occur at any age as a result of an injury or be associated with other joint-related conditions, such as gout or rheumatoid arthritis. Osteoarthritis initially affects the smooth cartilage lining of the joint.

This makes movement more difficult than usual, leading to pain and stiffness. Once the cartilage lining starts to roughen and thin out, the tendons and ligaments have to work harder.

This can cause swelling and the formation of bony spurs called osteophytes.

Severe loss of cartilage can lead to bone rubbing on bone, altering the shape of the joint and forcing the bones out of their normal position.

View original post here:
Paddy McGuinness health: Top Gear presenters shock diagnosis at the age of 44 - Express

Read More...

Rheumatoid Arthritis Therapeutics Market Worldwide Industry Share, Size, Gross Margin, Trend, Future Demand and Forecast till 2025 – Nyse Nasdaq Live

Sunday, February 16th, 2020

Global Rheumatoid Arthritis Therapeutics Market research report gives a comprehensive outlook of the markets 2019-2025 and offers an in-depth summary of the current market status, historic, and expected way forward for the Rheumatoid Arthritis Therapeutics Market. Additionally, to this, the report provides data on the restraints negatively impacting the markets growth. The report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the Market.

Download Free Sample Copy of Rheumatoid Arthritis Therapeutics Market Report: https://dataintelo.com/request-sample/?reportId=98577

Key Objectives of Rheumatoid Arthritis Therapeutics Market Report: Study of the annual revenues and market developments of the major players that supply Rheumatoid Arthritis Therapeutics Analysis of the demand for Rheumatoid Arthritis Therapeutics by component Assessment of future trends and growth of architecture in the Rheumatoid Arthritis Therapeutics Market Assessment of the Rheumatoid Arthritis Therapeutics Market with respect to the type of application Study of the market trends in various regions and countries, by component, of the Rheumatoid Arthritis Therapeutics Market Study of contracts and developments related to the Rheumatoid Arthritis Therapeutics Market by key players across different regions Finalization of overall market sizes by triangulating the supply-side data, which includes product developments, supply chain, and annual revenues of companies supplying Rheumatoid Arthritis Therapeutics across the globe

Major Players included in this report are as follows AbbVieBoehringer IngelheimNovartisRegeneron PharmaceuticalsPfizerBristol-Myers SquibbF. Hoffmann-La RocheUCB S.A.Johnson & Johnson ServicesAmgen

Rheumatoid Arthritis Therapeutics Market can be segmented into Product Types as PharmaceuticalsBiopharmaceuticals

Rheumatoid Arthritis Therapeutics Market can be segmented into Applications as PrescriptionOver-the-Counter (OTC)

To Buy this report, Visit https://dataintelo.com/checkout/?reportId=98577

Rheumatoid Arthritis Therapeutics Market: Regional analysis includes: Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.)

Target Audience: Rheumatoid Arthritis Therapeutics Equipment Manufacturers Traders, Importers, and Exporters Raw Material Suppliers and Distributors Research and Consulting Firms Government and Research Organizations Associations and Industry Bodies

Stakeholders, marketing executives and business owners planning to refer a market research report can use this study to design their offerings and understand how competitors attract their potential customers and manage their supply and distribution channels. When tracking the trends researchers have made a conscious effort to analyse and interpret the consumer behaviour. Besides, the research helps product owners to understand the changes in culture, target market as well as brands so they can draw the attention of the potential customers more effectively.

Customize Report and Inquiry for The Rheumatoid Arthritis Therapeutics Market Report: https://dataintelo.com/enquiry-before-buying/?reportId=98577

Report structure: In the recently published report, DataIntelo.com has provided a unique insight into the Rheumatoid Arthritis Therapeutics Industry over the forecasted period. The report has covered the significant aspects which are contributing to the growth of the global Rheumatoid Arthritis Therapeutics Market. The primary objective of this report is to highlight the various key market dynamics listed as drivers, trends, and restraints.

These market dynamics have the potential to impact the global Rheumatoid Arthritis Therapeutics Market. This report has provided the detailed information to the audience about the way Rheumatoid Arthritis Therapeutics industry has been heading since past few months and how it is going to take a shape in the years to come.

DataIntelo has offered a comprehensive analysis of the Rheumatoid Arthritis Therapeutics industry. The report has provided crucial information about the elements that are impacting and driving the sales of the Rheumatoid Arthritis Therapeutics Market. The section of competitive landscape keeps utmost importance in the reports published by DataIntelo. Competitive landscape section consists of key market players functioning in the worldwide industry of Rheumatoid Arthritis Therapeutics.

The report has also analysed the changing trends in the industry. Several macroeconomic factors such as Gross domestic product (GDP) and the increasing inflation rate is expected to affect directly or indirectly in the development of the Rheumatoid Arthritis Therapeutics Market.

Table of Contents 1 Industry Overview of Rheumatoid Arthritis Therapeutics 2 Manufacturing Cost Structure Analysis 3 Development and Manufacturing Plants Analysis of Rheumatoid Arthritis Therapeutics 4 Key Figures of Major Manufacturers 5 Rheumatoid Arthritis Therapeutics Regional Market Analysis 6 Rheumatoid Arthritis Therapeutics Segment Market Analysis (by Type) 7 Rheumatoid Arthritis Therapeutics Segment Market Analysis (by Application) 8 Rheumatoid Arthritis Therapeutics Major Manufacturers Analysis 9 Development Trend of Analysis of Rheumatoid Arthritis Therapeutics Market 10 Marketing Channel 11 Market Dynamics 12 Conclusion 13 Appendix

Ask for Discount on Rheumatoid Arthritis Therapeutics Market Report at: https://dataintelo.com/ask-for-discount/?reportId=98577

About DataIntelo: DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info DataIntelo Name Alex Mathews Email [emailprotected] Website https://dataintelo.com Address 500 East E Street, Ontario, CA 91764, United States.

More:
Rheumatoid Arthritis Therapeutics Market Worldwide Industry Share, Size, Gross Margin, Trend, Future Demand and Forecast till 2025 - Nyse Nasdaq Live

Read More...

Capable of handling triplets, but not the locks – GoDanRiver.com

Sunday, February 16th, 2020

Last week I talked about babysitting with the 3-year-old triplets Isla, Luke and Quinn. This week I want to talk about my challenge and eventual triumph over the child-proof locks in their home. It was not without drama.

There were six different types of locks in the house, none of which are suited for a 66-year-old woman who has flunked every kind of spatial test she has ever taken. I havent had to take many, but I have not scored nearly as well as I do on any given vocabulary test.

Here is a picture of a perfectly square box. Is it right-side up or upside-down? Mensa asks.

Box, I can offer. You spell it box.

And I have arthritis in my hands and have pretty much lost the ability to squeeze.

Thank goodness there was an 8-year-old and a 10-year-old sister in the house to help me during my lock-out. During the school day, however, I was on my own.

It was a school day when I first encountered the locked silverware drawer. There wasnt even anything on the outside that I could see. I pulled it out as far as I could, which wasnt far, and tried to push what looked like a lock down on the inside, but it didnt budge.

Isla didnt see me for some reason, or she would have looked at me through narrowed eyes like she does when she thinks Im pretty clueless. I had to wait until 8-year-old Faith got home and said, Oh, those are magnetic. There are magnets on the refrigerator and microwave to use.

So you rub those along the outside until you hear a click and the drawer magically opens. Or in my case, I hear a click and it doesnt open, and I call for an older child. I found out where the plastic ware was so I could live without silverware during the day.

Then there are some long lock things that fit into a thing with teeth. I figured that out but then put it back backward and Faith had to give me a lesson on that.

Moving on. The lock on the sink totally flummoxed me. (See. I spelled that hard word correctly, even if I wondered if you can be partially flummoxed or if flummoxation is always total. And I know its written right-side up.)

I sent a picture to my daughter with five kids in hopes she could help, even though she gave up on child-proof locks with child No. 2, I believe.

Just squeeze the little square things together to open it and then click it shut, she said. See above note about not having much finger squeezability anymore.

I finally got it and reopened it and just put what I needed from there on the counter so I didnt have to repeat that until Faith got home.

Now, the lock on the trash is broken. That is the lock I kept forgetting to close on my last visit and Luke fussed with me and Isla locked it for me. I dont think she realized I was not the one needing to stay out of the trash.

Luke also fusses if the lock on the water and ice dispenser on the refrigerator isnt locked. Wherever they are in the house, they can hear I have not silently held the spot down for three seconds and locked it. I either get reminded by a 3-year-old, or a 3-year-old pushes it and dispenses water on the floor.

Those locks are all in the kitchen. There are also locks on all the doors I have trouble with. I also have forgotten a couple of times to close the bathroom door when coming out, and that has been disastrous. A while back they unrolled toilet paper into the toilet and then Luke got upset because wet toilet paper was sticking to his hands. Isla didnt care.

I left it open again this trip after their parents got home and basically the same thing happened. My son helped me clean it up.

Is there anything I need to know about? the mother called from the next room.

Nope, I said, sopping up the floor.

My son whispered, You might want to wash their hands. They have been playing in the toilet, you know.

I dont remember if when my children were growing up, it was a jungle with a bunch of out-of-control monkeys, but maybe it was.

Or maybe Im just old(er), slow(er) and arthritic.

Brady seems to have idyllic memories of his childhood with every child behaving, so Ill just go with that.

As long as the triplets dont lock me out of their hearts, Ill be just fine.

Elzey is a freelance writer for the Register & Bee. She can be reached at susanelzey@yahoo.com or (434) 791-7991.

See original here:
Capable of handling triplets, but not the locks - GoDanRiver.com

Read More...

Psoriatic Arthritis (PsA) Treatment Market to Perceive Incremental Opportunity by 2018-2028 – Redhill Local Councillors

Sunday, February 16th, 2020

The Psoriatic Arthritis (PsA) Treatment Market is an intrinsic study of the current status of this business vertical and encompasses a brief synopsis about its segmentation. The report is inclusive of a nearly accurate prediction of the market scenario over the forecast period market size with respect to valuation as sales volume. The study lends focus to the top magnates comprising the competitive landscape of Psoriatic Arthritis (PsA) Treatment market, as well as the geographical areas where the industry extends its horizons, in magnanimous detail.

The market report, titled Psoriatic Arthritis (PsA) Treatment Market Research Report 2019 By Manufacturers, Product Type, Applications, Region and Forecast to abc, recently added to the market research repository of details in-depth past and present analytical and statistical data about the global Psoriatic Arthritis (PsA) Treatment market. The report describes the Psoriatic Arthritis (PsA) Treatment market in detail in terms of the economic and regulatory factors that are currently shaping the markets growth trajectory, the regional segmentation of the global Psoriatic Arthritis (PsA) Treatment market, and an analysis of the markets downstream and upstream value and supply chains.

ThisPress Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at https://www.xploremr.com/connectus/sample/3664

The report offers the market growth rate, size, and forecasts at the global level in addition as for the geographic areas: Latin America, Europe, Asia Pacific, North America, and Middle East & Africa. Also, it analyses, roadways and provides the global market size of the main players in each region. Moreover, the report provides knowledge of the leading market players within the Psoriatic Arthritis (PsA) Treatment market. The industry-changing factors for the market segments are explored in this report. This analysis report covers the growth factors of the worldwide market based on end-users.

In accordance with a competitive prospect, this Psoriatic Arthritis (PsA) Treatment report dispenses a broad array of features essential for measuring the current Psoriatic Arthritis (PsA) Treatment market performance along with technological advancements, business abstract, strengths and weaknesses of market position and hurdles crossed by the leading Psoriatic Arthritis (PsA) Treatment market players to gain leading position. Other aspects such as customer base, sales reach, local coverage, production price trends, and production cost layout are also analyzed to bestow accurate rivalry perspective.

Get Your Copy at a Discounted Rate!!! Limited Time Offer!!! https://www.xploremr.com/connectus/check-discount/3664

Pivotal highlights of Psoriatic Arthritis (PsA) Treatment market:

The Psoriatic Arthritis (PsA) Treatment market report includes a brief about the cost analysis, key raw material used, as well as the fluctuating price trends of the war material.

The suppliers of the raw material and their market concentration rate have also been enlisted.

The manufacturing cost structures, encompassing details about the raw material, manufacturing process analysis, as well as labor costs have been enumerated in the study.

Substantial details about the industry chain analysis, downstream buyers, and sourcing strategies have been elucidated.

A separate section has been designated for the analysis of the marketing strategy adopted, as well details about the distributors that are a part of the supply chain.

The report is inclusive of information regarding the channels adopted for the product marketing, marketing channel development trends, pricing and brand strategies, as well as target clientele.

Get Full Report Access athttps://www.xploremr.com/cart/3664/SL

Why Companies Trust XMR?

About Us

XploreMR is one of the worlds leading resellers of high-quality market research reports. We feature in-depth reports from some of the worlds most reputed market research companies and international organizations. We serve across a broad spectrum from Fortune 500 to small and medium businesses. Our clients trust us for our unwavering focus onquality and affordability. We believe high price should not be a bottleneck for organizations looking to gain access to quality information.

Contact us:XploreMR111 North Market Street, Suite 300,San Jose, CA 95113, United StatesPh.No: +16692840108E-mail id- [emailprotected]

Read more:
Psoriatic Arthritis (PsA) Treatment Market to Perceive Incremental Opportunity by 2018-2028 - Redhill Local Councillors

Read More...

Arthritis Foundation

Friday, January 10th, 2020

As a partner, you will help the Arthritis Foundation provide life-changing resources, science, advocacy and community connections for people with arthritis, the nations leading cause of disability. Join us today and help lead the way as a Champion of Yes.

Our Trailblazers are committed partners ready to lead the way, take action and fight for everyday victories. They contribute $2,000,000 to $2,749,000

Our Visionary partners help us plan for a future that includes a cure for arthritis. These inspired and inventive champions have contributed $1,500,00 to $1,999,999.

Our Pioneers are always ready to explore and find new weapons in the fight against arthritis. They contribute $1,000,000 to $1,499,999.

Our Pacesetters ensure that we can chart the course for a cure for those who live with arthritis. They contribute $500,000 to $999,000.

Our Signature partners make their mark by helping us identify new and meaningful resources for people with arthritis. They contribute $250,000 to $499,999.

Our Supporting partners are active champions who provide encouragement and assistance to the arthritis community. They contribute $100,000 to $249,999.

Go here to see the original:
Arthritis Foundation

Read More...

Manifestations of Inflammation and Pain Flares in Rheumatoid Arthritis – Rheumatology Advisor

Friday, January 10th, 2020

Flaresare common in patients with rheumatoid arthritis (RA), but many experiencediscordant inflammation and pain flares, according to study results publishedin BMC Rheumatology.

The study included patients from the Early RA Network (ERAN) cohort (n=719). The researchers assessed patients annually up to 11 years after presentation (3703 person-years of follow-up). The researchers defined flare events in 2 different ways, which were analyzed in parallel: Disease Activity Score-28 (DAS28) or pain flares. DAS28 flares satisfied Outcome Measures in Rheumatology (OMERACT) flare criteria: increases in DAS28 since the previous assessment (1.2 points if active RA or 0.6 points if inactive RA). Pain flares were defined as a 4.8-point worsening of Short Form Health Survey 36-Bodily Pain score.

Theresearchers analyzed the first documented episode of each DAS28 and pain flarefor each patient. They then used latent class analysis to determine subgroupswith DAS28 and pain flares and compared clinical courses between subgroups.

Afteranalyzing the results, the researchers found that 45% of patients experiencedDAS28 flares and 52% experienced pain flares. Flares were usually discordant,with 60% of patients with DAS28 flare not concurrently in pain flare and 64% ofpatients with pain flare not concurrently in DAS28 flare.

Theresearchers identified 3 distinct DAS28 subgroups: the first characterized byincreases intender/swollen joint count (14.4%); the second by increases in symptoms (13.1%);and the third, which displayed lower flare severity (72.5%). They alsoidentified 2 discrete pain flare subgroups: in the first the pain flare occurredfollowing low disease activity and symptoms (88.6%) and in the second occurredon the background of ongoing active disease and pain (11.4%).

WhileDAS28 and pain flares had observed differences, both were associated withincreased disability, which persisted after the flare.

Thestudy included several limitations. The researchers noted that assessments maynot have captured data during a flares peak, while pre-flare data may notreflect the patients best clinical status. In addition, missing data may haveinfluenced the study findings.

DAS28and pain flares are discrete entities indicative of differing underlyingmechanisms, but both have immediate patient impact and lead to longer termdisability. Identifying and understanding RA flare subgroups should guidetreatment, the researchers wrote.

Disclosure: Several study authors declared affiliations with thepharmaceutical industry. Please see the original reference for a full list ofauthors disclosures.

Reference

McWilliams DF, Rahman S, James RJE, et al. Disease activity flares and pain flares in an early rheumatoid arthritis inception cohort; characteristics, antecedents and sequelae. [published online November 18, 2019]. BMC Rheumatol. doi:10.1186/s41927-019-0100-9

Continued here:
Manifestations of Inflammation and Pain Flares in Rheumatoid Arthritis - Rheumatology Advisor

Read More...

Which Joints Are Most Affected by Arthritis? – Yahoo Lifestyle

Friday, January 10th, 2020

Like many diseases, arthritis is not a one-size-fits-all illness. To explain it in the easiest wayor in the most general termsthink of arthritis in two overarching categories. "As a broad classification, you have inflammatory versus non-inflammatory arthritis," explains Dr. Natalie Azar, rheumatologist and clinical assistant professor in the department of medicine at NYU Langone Health. "We don't categorize arthritis by the joints affected, but by inflammatory versus non-inflammatory." Osteoarthritisthe non-inflammatory kindis synonymous with wear and tear. (It's generally the kind that occurs as you get older.) Rheumatoid arthritisthe inflammatory kindis systemic and associated with autoimmune diseases.

Witthaya Prasongsin/Getty

Osteoarthritis most commonly affects the knees ("Think of how many people get knee replacements," Dr. Azar says), as well as the hips and hands. While it is genetic, and can be associated with trauma, like fractures. Obesity can also lead to osteoarthritis, since you're putting too much pressure on your joints, Dr. Azar explains. For people afflicted with osteoarthritis, there unfortunately aren't any FDA-approved medicines that can change the course of the disease. "We're still left treating symptoms," Dr. Azar says. Physical therapy can help strengthen jointsand taking Tylenol to ease pain and inflammation can offer short-term, immediate relief to those dealing with both types of arthritis.

Related: These Are the Best Supplements for People Living with Arthritis

Rheumatoid arthritis, on the other hand, can affect small or large jointstypically four or more. "It's symmetrical, so both sides of the body are involved," Dr. Azar says. "It's not just one knee, but both knees, or both wrists, or both joints of the hands. It's also associated with swelling, stiffness that lasts for more than an hour, and pain." Rheumatoid arthritis, she says, can also affect the kidney and lungsit's not just a joint disease. Fortunately, with rheumatoid arthritis, there are disease-modifying therapies (or anti-rheumatic drugs) that patients can take in order to put them into remission and reverse damage, Dr. Azar explains.

And while diet doesn't cause either type of arthritis, once you have it (regardless of type), eating an inflammatory diet can exacerbate the situation, Azar says; alcohol, processed sugars, and trans fats are the usual culprits. Following an anti-inflammatory diet full of fruits, vegetables, lean protein, and healthy fats may help boost the immune system, fight inflammation, and strengthen bones, the Arthritis Foundation says. Azar refers patients to the site for information and health tips on what to eat while living with arthritis, but she adds that the dietlike the diseaseis not one-size-fits all. Some people can't tolerate nightshade vegetables like tomatoes, eggplants, and potatoes, for example, so you just have to experiment and tailor your diet to see what makes you feel your best.

See the original post:
Which Joints Are Most Affected by Arthritis? - Yahoo Lifestyle

Read More...

Arthritis: Include this type fish in your diet to alleviate joint pain – Express

Friday, January 10th, 2020

Arthritis is an umbrella term for a number of conditions that cause swelling and tenderness in one or more of your joints.

The main symptoms of arthritis are joint pain and stiffness, which typically worsen with age.

Osteoarthritis and rheumatoid arthritis are the two most common types of arthritis, and, while these conditions cannot be cured, lifestyle interventions can be taken to alleviate joint pain associated with them.

Certain foods, for example, have been shown to contain anti-inflammatory properties, and fatty fish, such as salmon, mackerel, sardines and trout, are high in omega-3 fatty acids, which have shown to produce potent anti-inflammatory effects.

In one small study, 33 participants were fed either fatty fish, lean fish or lean meat four times each week.

After eight weeks, the fatty fish group had decreased levels of specific compounds related to inflammation.

Echoing these findings, an analysis of 17 studies found that taking omega-3 fatty acid supplements decreased joint pain intensity, morning stiffness, the number of painful joints and use of pain relievers in patients with rheumatoid arthritis.

READ MORE:Best supplements for joints: The anti-inflammatory supplement proven to relieve joint pain

Exercise may seem counterintuitive if you are in pain, but in addition to helping you lose weight, it can also help to reduce and prevent pain associated with arthritis.

As the NHS points out, exercise can also help:

As long as you do the right type and level of exercise for your condition, your arthritis won't get any worse, explains the health body.

It added: Combined with a healthy, balanced diet, regular exercise will help you lose weight and place less strain on your joints.

According to Versus Arthritis, the UK's largest charity dedicated to supporting people with arthritis, you should aim to do at least 30 minutes of exercise that makes us a bit short of breath five times a week.

Its also recommended that you spend 30 minutes a day on our feet, such as walking or climbing stairs, notes the charity.

If you have joint pain, start gently and gradually increase the length of time youre exercising. You can break this into smaller chunks if you need to, advises the health body.

It added: Doing five to ten minutes of exercise each day is important to keep your joints moving and your muscles strong.

As the NHS explains, if you have arthritis, carrying out tasks around the home can be a challenge, however, making some practical changes to your home and changing the way you work should make things easier.

Practical tips that could help include:

An occupational therapist can also help if you have severe arthritis that's affecting your ability to move around your home and carry out everyday tasks, such as cooking and cleaning, notes the health body.

They can advise about equipment you may need to help you live independently, and, depending on the exact nature of your condition, your GP may be able to refer you to an NHS occupational therapist, adds the health site.

Visit link:
Arthritis: Include this type fish in your diet to alleviate joint pain - Express

Read More...

Vitamin D deficiency symptoms: A lack of the vitamin may cause pain in this body part – Express

Friday, January 10th, 2020

Vitamin D is a fat-soluble vitamin that is naturally present in very few foods, and available as a dietary supplement. Vitamin D plays a role in insulin production and immune function. Although the amount of vitamin D adults get from their diets is often less than whats recommended, exposure to sunlight can make up the difference.

Research has found that vitamin D may play a significant role in joint health, and that low levels may increase ones risk of rheumatological conditions such as arthritis.

Several studies have found low blood levels of vitamin D in patients with osteoarthritis of the hip and knee.

In another study of more than 2,000 people, researchers found that vitamin D deficiency was strongly associated with a disabling symptoms among those with rheumatoid arthritis.

DONT MISS

Why does a lack of vitamin D affect bones?

Vitamin D helps the bones absorb calcium, which is vital to bone health.

The vitamin is also crucial for muscle movement, communication between nerves, and fighting inflammation.

According to the Arthritis Foundation, people who take oral steroids have a vitamin D deficiency twice as often as people who dont take them.

Oral steroids are a common treatment for people with arthritis.

What studies have said

In a study with Endocrinology and Metabolism, the link between vitamin D and rheumatoid arthritis was investigated.

The study concluded that vitamin D deficiency is highly prevalent in patients with rheumatoid arthritis and that vitamin D deficiency may be linked to disease severity in rheumatoid arthritis.

As vitamin D deficiency has been linked to diffuse musculoskeletal pain, these results have therapeutic implications vitamin D supplementation may be needed both for the prevention of osteoporosis as well as for pain relief in patients with rheumatoid arthritis.

In addition to helping prevent arthritis, getting enough vitamin D may also lower the risk for other autoimmune diseases like cancer, heart disease, type 2 diabetes, bone fractures, depression and the flu.

During winter its highly recommended to take vitamin D supplements.

Doctors recommend taking 800 to 1,000 IU of vitamin D a day. Other symptoms of a vitamin D deficiency include pain, infections, gastrointestinal problems, depression and weak bones.

Read the original post:
Vitamin D deficiency symptoms: A lack of the vitamin may cause pain in this body part - Express

Read More...

Secukinumab has Early and Sustained Efficacy on Enthesitis in Patients with Psoriatic Arthritis – Pharmacy Times

Friday, January 10th, 2020

Secukinumab has Early and Sustained Efficacy on Enthesitis in Patients with Psoriatic Arthritis

Enthesitis is inflammation of the entheses, the site where ligaments or tendons insert into the bones. Common locations for enthesitis include the bottom of the feet, the Achilles tendons, and the places where ligaments attach to the ribs, spine, and pelvis.2

Patients with enthesitis are known to have worse outcomes than patients without enthesitis. Using pooled data from the FUTURE 2 and 3 studies, a research team explored the use of secukinumab to limit enthesitis in patients with PsA.1

FUTURE was a phase 3 randomized, double-blind, placebo-controlled multicenter study that analyzed the 24- to 52-week efficacy, safety, and tolerability of subcutaneous secukinumab in prefilled syringes. Researchers used the Leeds Enthesitis Index (LEI) that consists of 6 sites: bilateral Achilles tendon insertions, medial femoral condyles, and lateral epicondyles of the humerus. Tenderness at each site is quantified by a number scale: 0 means nontender and 1 means tender.4

The post hoc analyses included the resolution of enthesis count (EC=0), median time to first resolution of enthesitis, and shift analysis of baseline EC (1, 2, or 3-6) to full resolution (FR) stable (similar or reduction of EC), or worse (EC > baseline).1

Sixty-five percent (466/712) of patients had baseline enthesitis. In the overall population, FR was achieved as early as week 16 in 65% (300 mg) and 56% (150 mg) versus 44% in the placebo group, with further improvements to 91% (300 mg) and 88% (150 mg) at week 104. The majority (89%) of patients without enthesitis at baseline maintained their status at week 104.3

In patients with EC of 1 or 2, shift analysis from baseline to week 24 showed that more patients achieved FR with secukinumab 300 mg and 150 mg versus placebo, whereas no difference between secukinumab and placebo was shown in patients with more severe symptoms with an EC of 3 to 6. Improvements in efficacy outcomes were similar in patients with or without enthesitis treated with secukinumab 300 mg.1

Secukinumab provided early and sustained resolution of enthesitis in patients with PsA over 2 years, the study authors noted.1 Secukinumab 300 mg provided higher resolution than 150 mg in patients with more severe baseline EC and showed similar overall efficacy in patients with or without enthesitis.

Reference

See the original post here:
Secukinumab has Early and Sustained Efficacy on Enthesitis in Patients with Psoriatic Arthritis - Pharmacy Times

Read More...

JIA Orofacial Pain Linked to Stress, Activity Limitations, Study Shows – Juvenile Arthritis News

Friday, January 10th, 2020

People withjuvenile idiopathic arthritis (JIA) who experienceorofacial pain pain in the mouth, face, and jaw have more stress, limitations on daily activities, disease activity, and systemic inflammation than those who do not, a study reports.

The study, Orofacial pain in juvenile idiopathic arthritis is associated with stress as well as psychosocial and functional limitations, was published in the journal Pediatric Rheumatology.

The hallmarks of JIA are swelling of the joints, pain, and stiffness, typically in the knees, hands, or feet. JIA can affect other joints as well, such as those that connect the jaw to the head, which are known as the temporomandibular joints (TMJ).

Up to 96% of children with JIA develop TMJ arthritis, where stiffness, crepitus (joint popping), and restricted mouth opening are often reported.

Chronic or recurrent pain and disability in children and adolescents can limit their ability to function and grow properly. Many of these patients refrain from going to school and avoid engaging in social activities due to the psychosocial stress and pain associated with the disorder.

To investigate the relationship between psychosocial stress, along with inflammatory activity, and pain and function of the jaw, a group of researchers in Sweden studied 45 JIA patients ages 6 to 16. Sixteen children without JIA were also included as controls.

A clinical assessment, including both a physical and a psychosocial component, was conducted on all participants by one dentist.

Pain intensity and pain-related disability were assessed with the Graded Chronic Pain Scale. Limitations to jaw function was evaluated using the Jaw Functional Limitation Scale.

A four-item Patient Health Questionnairewas used to assess depression and anxiety symptoms. The Pain Catastrophizing Scale was applied to determine the degree of catastrophizing (believing pain is worse than it is), and the 10-item Perceived Stress Scale was used to evaluate stress.

The Childhood Health Assessment Questionnaire was used to assess ability to conduct daily life activities among children with JIA, while the body-drawing part of the McGill Pain Questionnaire was used to record pain locations.

Finally, the team used the Juvenile Arthritis Disease Activity Score,which includes an active joint count, a physician global assessment, a parent global evaluation, and the erythrocyte sedimentation rate (an indicator of systemic inflammation).

Results showed a strong association between experiencing orofacial pain and stress. Among patients scoring higher (worse) than normal in perceived stress, eight out of ten had self-reported orofacial pain.

Orofacial pain also significantly correlated with pain-related disability, depression, pain catastrophizing, and limitations in daily activities.

The team then compared clinical and psychosocial factors of JIA patients who experienced jaw pain with those who did not.

Orofacial pain was significantly associated with pain intensity, maximum mouth opening, and limitations on jaw functioning. JIA patients with orofacial pain also had higher disease activity and systemic inflammation than those without such pain.

In contrast, neither depression nor pain catastrophizing were linked to orofacial pain.

This study indicates that orofacial pain in patients with JIA is associated with stress, psychological distress, jaw dysfunction and loss of daily living activities, the researchers said.Pain intensity seems to be the major aspect related to these factors. In addition, increased disease activity with more joint involvement seems to be an important factor contributing to orofacial pain in JIA.

Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where hes helping make medical science information more accessible for everyone.

Total Posts: 11

Jos is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimers disease.

Visit link:
JIA Orofacial Pain Linked to Stress, Activity Limitations, Study Shows - Juvenile Arthritis News

Read More...

Why I Relate to ‘Survivor’ as Someone With Rheumatoid Arthritis – Yahoo Lifestyle

Friday, January 10th, 2020

I spent my summer watching Survivor. You know, the reality television show that shows people living in rugged, beautiful climates, taking part in challenges and voting each other off the island every few days. I was a fan when it started in 2000, but over the years, schedules and life turned my attention to other viewing pleasures.

Back then, I liked the beautiful settings and the intrigue among the cast members who were creating these intense relationships from living together in harsh circumstances and then back-stabbing those same people as part of the game. But what I really loved were the challenges. These usually took the form of giant obstacle courses, either on a sandy beach or in the ocean. Contestants swam, jumped, dug, wiggled and ran their way to winning rewards or immunity from being voted off. I liked to think about how I would do that and what skills I would bring to such fun.

Related: 10 'Hidden' Symptoms of Rheumatoid Arthritis We Don't Talk About

But this summer was different.

After years away from the show, this summer I found 34 seasons on Hulu and binged my way through season after season. I was able to do this because this summer a rheumatoid arthritis flare that included severe back pain and fatigue put me in bed with just a phone and a remote. I spent hours watching Survivor, drawn in by something internal and strong. At first, I wasnt sure what the lure was, but then it occurred to me.

I saw myself on that screen, except this time through the lens of my new reality.

When contestants would swim into the ocean, climb a ladder to retrieve a special key, then swim back, struggling to pull themselves on to a platform, I saw myself. I recognized that deep, unshakable fatigue, even though the genesis was different for them than for me.

When it rained for five days straight and their fire went out so they could only eat coconut in wet clothes, I recognized the despair on their faces from not knowing when this particular pain would end.

Related: 13 Things People Who Have to Give Themselves Shots Wish Others Understood

When a downcast contestant would dig deep and finish a challenge just when they needed the win, I found inspiration in my own battle for a win.

When their families showed up as a surprise reward, I wept from knowing how sustaining that unconditional love is and the hope it brings.

Yes, I saw myself in these Survivor contestants. No, I wasnt wearing a bathing suit on national TV or wrestling another person to try to win fishing gear, but I was in my own battle. It was a battle that included pain, despair, fatigue and hope. It was a battle that meant I had to will all my internal strength to be the victor. And as summer ended and my pain eased, I realized that I too, in my own reality, could call myself a Sole Survivor.

5 Tips for Success With Medical Cannabis

What Its Like When Doctors Blame You for Your Chronic Illness

8 Ways to Partner With Your Doctor and Take Charge of Your Healing

How I Took Walking for Granted

Read the original post:
Why I Relate to 'Survivor' as Someone With Rheumatoid Arthritis - Yahoo Lifestyle

Read More...

Doctors Missed Her RA Symptoms in Pregnancy. She Found a Way to Thrive Anyway – HealthCentral.com

Friday, January 10th, 2020

Brooke Baker was sleeping soundly one night in 2005 when suddenly she woke up with new and excruciating pain in both shoulders. "I remember it so well, and I had no idea what was going on," recalls the Oklahoma native, now 39. "The pain was like someone was injuring me, and I couldn't go back to sleep for hours."

In the agonizing days to come, a perplexed and frightened Baker swapped out her mattress and her pillow and would prop herself up to try and alleviate the unrelenting stabbing sensations.

I just thought, Well, it must be one of those things, she says. But then that thing moved to her elbows, the next week to her wrists, and a week later, to her hands. I had never had any pain issues, and this all made me feel so debilitated. Having such painful arms and hands was especially unfair. Baker had been a full-time music minister at church for three years, playing the piano.

Realizing the continuing torment was anything but random, she went to see her OB/GYN. After all, she was eight weeks into a miracle pregnancy at the time (shed been told shed never be able to have children). The last thing she needed was unexplainable pain.

When I said: Something's wrong, during that office visit, both the nurse and the male doctor I saw told me I should be grateful to be pregnant and basically to suck it up, she says. Baker vowed to find a new OB/GYN, which she did four months into her pregnancy. At that point the pain was in every joint, from her neck to her toes.

This doctor was a little gentler, he did really listen, but he was also a poor communicator, Baker says. Because her symptoms were suspicious, the doctor did refer her to a local rheumatologist who ran some tests to confirm or rule out the possibility of rheumatoid arthritis (RA). That was the first mention that this disease could be the cause of her pain.

The rheumatologist later called me to report the results showed nothing, Baker says. Later, he also told me it definitely wasn't RA and that RA gets better when you're pregnant.

With her diagnosis still undetermined, the now-devastated and overwhelmed mother-to-be was in too much pain to work, so she quit and moved back in with her parents, because on top of all of this, her marriage had fallen apart.

I was on the couch for almost seven months, she says. The pain got better for about six weeks, between months seven and eight, says Baker. I finally felt better and hoped I was over it all.

It wasn't to be. The pain returned full force during her ninth and final month of pregnancy as she was also getting huge, she says. Almost sheepishly, she returned to her OB/GYN for pain relief. I didn't want anyone, including him, to think I was crazy.

That doctor told her: When you have the baby, you won't hurt anymore. Wrong: Her pain kept steadily increasing.

The calendar had flipped to 2006 now and the big day came to deliver. A c-section was complicated by my previous abdominal surgeries and resulted in a longer hospital stay and blood transfusions, Baker says. But my baby boy, Jackson, was healthy and I was thrilled!Still, her intense joint pain persisted. How would she manage being a single mother? Her doctor then told her: When you stop breastfeeding, you won't hurt anymore. But when she stopped after a year, her pain continued on.

I thought, If I just tough it out longer, I'll be OK, she says. I was pretty gullible, believing everything I was told.

Being a single mom is hard enoughbut fate would deal her another unlucky hand. Baker was worried: It seemed that Jackson, then 17 months old, was drinking constantly. Then one day he began stumbling, he couldnt see normally, and he'd been losing weight. She knew something was terribly wrong.

A doctor visit and blood tests showed his blood sugar was more than 750 mg/dL when he was diagnosed with type 1 diabetes. (Normal blood sugar for a person without diabetes ranges from between 70 and 100 mg/dL.) Frequent urination, thirst, fatigue, and weight loss are common symptoms of the disease.

He was too young to tell me what was wrong, how he was feeling, says Baker. His behavior changes and voice gave her clues as she tested his blood sugar regularly.

Baker was in nursing school by this time, still living with her parents and not working, except to play music part-time at a little, bitty job, she says.

In those first stressful weeks after his diagnosis, I'd stay up studying until 2 a.m., check my son, then sleep till 5 a.m. or 6 a.m. and then start it all over again, Baker says, knowing it was all worth it, even though then, it all felt almost unbearable.

I went through the roof at that time, Baker says, recalling seemingly insurmountable stress. Three weeks after her son's diagnosis, she finally saw her primary-care provider, where she wished she'd started, and tearfully confessed that she couldn't move her arms.

I couldn't even lift my baby. I'd have to scoop him, she says. I'd spend 30 minutes in the shower, in the warm water, to help get my arms moving in the morning, because they were 'locked' at a 90-degree angle.

The situation was terrifying. The baby relied on me for everythingme, the single mother trying to do everythingand I could barely take care of myself. I couldn't open a baby food jar, and didn't feel safe bathing him alone, Baker says. Thank goodness for my mother. But this was about survival, and I had to go on.

Her healthcare provider immediately did new blood tests for RA and he called Baker the same night to confirm positive results. "I was so glad to have an answer that I wasn't even devastated by that news," she says. The previously reported test resultsthe ones that ruled out RA while she was pregnantmust have been a mistake, she thinks now.

Her doctor quickly referred her to another rheumatologist who didn't just mumble and grunt at me, she says. He prescribed medication, and I started it in December 2007.

As for why Bakers OB/GYN had earlier ruled out RA because her symptoms continued during pregnancy, which, he said, was not the normit turns out he was half right and half wrong.

The latest research in UpToDate, an evidence-based clinical resource, says approximately 50% to 60% of pregnant women diagnosed with RA do have improvement in their symptoms, usually starting in the first trimester. And no, it's not possible to predict which patients will improve and which will flare.

Even more specifically, a review recently published in The Journal of Rheumatology reported that disease activity improved in 60% of patients with RA in pregnancy and flared in 46.7% postpartum. The Arthritis Foundation says that may be because of the hormone and immune system changes that protect an unborn child may also help RA.

The RA medication her doctor started her on was methotrexate, and it still stabilizes Baker's RA. It's a disease-modifying anti-rheumatic drug also known as a DMARD and it's considered a first-line treatment for RA. As the Johns Hopkins Arthritis Center shares, its benefits include that it works fairly quicklyin six to eight weeksit works well, is easy to use, and isn't expensive.

Bakers joints throbbed when she started taking it. She'd feel good for a few days, and then after the next week's injection, the pain would return. It took seven months before I started to feel normal, again, but a year later I was pretty much functional and able to play piano again! she says.

Baker has gone back and forth between methotrexate pills and now-weekly injections. She feels so much better now that she shudders to remember the two miserable years she spent with no pain medication except acetaminophen.

No one ever gave me any, she says. They just said: Everyone hurts when they're pregnant.

Jackson, Bakers now 13-year-old son, has clearly inherited his mother's indomitable, can-do attitude. His spirit is undefeatable, and he just bounces back with a resiliency that's amazing, Baker says of her son. His hasn't been an easy life and he makes it look so easy.

When Jackson doesn't feel well, he doesn't let it bother him. Instead he asks: "Can I go to school tomorrow? Baker patiently explains that he should rest and asks him to pace himself.

She homeschooled him until fifth grade and he thrived when he eventually attended school. Hes so motivated, just so driven, and wants to get into Harvard, she says. Hes also creative and talented and plays the lead in lots of school plays.

Getting to this point has meant thatmuch like his momJackson has had to overcome the awful moments that come with chronic illness. Baker recalls when, as a child, Jackson would say, I don't want to be diabetes, Mommy.

That was just heart-wrenching, Baker says. Now he's so calm, and he says to me: Diabetes isn't all that bad. There are more good things than bad things. That stumps me, and I just go blank, without a response.

He has said he doesn't quite understand it all, about why he hurts and can't get better, and why she hurts, too. Hes starting to assess when my hands and feet swell, and he says Im so sorry you have this rheumatism, she says.

Baker doesn't dwell on sorry, but stays active. She is part of the Diabetes Patient Advocacy Coalition that advocates for more affordable insulin. Shes been to Washington, D.C. three times in 2018 and 2019 to lobby her legislators to decrease the price of insulinand she intends to continue. As a partial result of the groups nationwide efforts, the Insulin Price Reduction Act was introduced July 22, 2019.

Baker isnt looking for a standing ovation, but she measures her lifes progress quietly every day, her eye firmly on the prizeand her goals.

With her pain controlled, and now her stress, Baker, who lives with her son, can focus on her accomplished life. She began that nursing degree in January 2008, around the time both she and her son were diagnosed with their diseases, and she finished in May 2010. Then in January 2019, she finished her masters degree in nursing and now works as a professor at a local university teaching the next generation of nurses. She will pursue her Ph.D. next, with the goal of becoming a university dean. Then there are more personal goals.

I want to be more active with my son when I can, Baker says. My body's getting physically stronger, and we're planning to do some runs together soon.

And theres travel. The pair plans to visit all 50 states. She's done 47, and Jackson has logged 10. Baker still plays music for therapy, not performing, but singing joyfully with her son in the car.

Shes relieved not to have to fight her body anymore. I'm trying to work with it instead of against it, she says. I dont accept it as: Boy, I love having this, but it's better than hating it all the time.

RA Reminds Her That Pain is Real, and Personal

Baker takes a whole-body approach to managing her RA. She consistently takes her medicationon timeand also likes to use essential oils for aromatherapy and for minor relief, applying them to her hands. To maintain her overall balance, she practices yoga, her favorite activity. She embraces deep breathing and calming apps on her phone, such as Calm and Headspace.

I do my part, and because I have a spiritual side, I leave the rest because I can't control it all, she says.

Baker remembers the time when doctors didnt hear her when she reached out for help with pain and she felt sheepish about pressing themnot so now. She encourages others with chronic illness to speak up for themselves. Youll experience a real difference between advocating and not, and if you dont find support in doctors you have, keep trying until someone really listens to you and works with you, she says.

It's made her a better nurse, especially when a patient shares about their pain. She learned in nursing school that pain is what the patient says it is. Baker knows this firsthand. Those months of gritting through intense pain during her pregnancy could have been shortened if only someone had really listened to her symptoms and pushed for treatment. Now Baker is doing the listening (and teaching) and her patients are lucky to have her.

See more helpful articles:

Let's Talk About Rheumatoid Arthritis

9 Conditions That Mimic RA

13 Supplements That Can Help Your RA

Read the original here:
Doctors Missed Her RA Symptoms in Pregnancy. She Found a Way to Thrive Anyway - HealthCentral.com

Read More...

Tai-Chi, Topical Capsaicin Among the New Treatment Recommendations for Osteoarthritis – Rheumatology Network

Friday, January 10th, 2020

The American College of Rheumatology (ACR), in partnership with the Arthritis Foundation, has issued treatment guidelines for osteoarthritis of the hand, hip and knee. This is the first update since 2012.

New in this release is the inclusion of patients in the decision-making process, which the Arthritis Foundation described a "patient-centric guidelines."

Traditionally, the patient voice has been invoked, but not always present, as guidelines are developed, said Guy Eakin, senior vice president of scientific strategy for the Arthritis Foundation. Through our partnership we were able to marry the ACR rheumatology expertise with the Live Yes! patient community to pioneer a process assuring guidelines that treat patients reflect the unique perspectives of the patients who will receive them.

The guidelines, which will be published in February in an ACR journal, emphasizes the adoption of basic therapeutic treatments which were strongly recommended. These include: weight loss; self-management programs to build fitness skills and exercise goalsetting. Previously consider conditions recommendations, the following were upgraded to strong recommendations: mind-body approaches such as tai-chi; topical NSAIDs for knee and hand osteoarthritis; oral NSAIDs and intra-articular steroids for knee and hip osteoarthritis.

Other recommendations include:

REFERENCE: Sharon L. Kolasinski, Tuhina Neogi, Marc C. Hochberg, et al. "2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee." January 2020. Arthritis Care and Research. DOI:10.1002/acr.24131

See the original post here:
Tai-Chi, Topical Capsaicin Among the New Treatment Recommendations for Osteoarthritis - Rheumatology Network

Read More...

Lyme disease: Justin Bieber’s tick-bite illness can cause joint pain, heart problems, and depression – The Conversation UK

Friday, January 10th, 2020

Justin Bieber recently announced that for the last couple of years hes been battling Lyme disease. Lyme disease, which is caused by the bacterium Borrelia burgdorferi, can be transmitted to humans if theyre bitten by an infected tick. In fact, its one of the most common tick-borne diseases in the west. An estimated 300,000 people in the US are diagnosed with it every year. The disease causes a range of debilitating symptoms, which can include severe headaches, neck stiffness, arthritis, joint pain and rashes. These symptoms can last for months or even years.

After being bitten, most people develop a red, circular rash, which may slowly expand beyond the bite site. Only around 20-30% of people will develop the characteristic bullseye rash. Without prompt treatment, the bacteria will spread from the bite site to tissues and organs, leading to additional skin lesions and a range of debilitating and persisting symptoms, such as pain, fatigue, memory problems and arthritis.

Perhaps alarmingly, instances of Lyme disease have actually become more common. In England and Wales the number of cases has increased from 1,134 in 2016 to 1,579 cases in 2017. The increase might be explained by a number of factors, including global warming (ticks survive better in warm weather) and increasing wildlife populations. Better diagnostic tools and increased awareness might also explain the surge in Lyme disease diagnoses.

Lyme disease can have a considerable impact on many aspects of the lives of the patient and their families. In severe cases, patients can be bedridden or wheelchair-bound for years without knowing if they will recover. Affected people may also experience anxiety, depression or distress, which can reduce their quality of life and deeply affect their mental wellbeing potentially even resulting in thoughts about suicide.

In most cases, a person will be diagnosed with Lyme disease based on whether they have the illnesss characteristic skin lesions especially if they live in an area where ticks carry Lyme disease. Although blood tests can also be used, these tests might only be 30-40% effective at detecting the disease in its early stages. But if the disease has already spread throughout a persons body, these results can be 100% accurate.

Giving a clear diagnosis of Lyme disease can be difficult, however. This is because many patients have a range of non-specific clinical symptoms, such as fatigue, malaise, headache, fever, sweats, joint aches and brain fog. Disease test results might also be similarly difficult to interpret, especially in patients that do not have the hallmark skin rash of Lyme disease and lack a recent history of exposure to tick bites. This makes dealing with the lingering infection difficult, especially where tests give inconclusive results.

In fact, people suffering from Lyme disease can also suffer from other tick-borne illnesses, such as babesiosis, which can be transmitted with Borrelia burgdorferi during the tick bite. This makes treatment even more complicated. As well, there is still some controversy about the right length of effective antibiotic therapy to treat patients with persistent, chronic Lyme disease. As a result, patients can, and usually do, feel helpless amid conflicting medical advice in fighting the disease.

Lyme disease is primarily treated with antibiotics. Early skin lesions and symptoms can be treated with the oral antibiotic doxycycline, usually for anywhere between ten to 21 days. Patients with neurological symptoms (including meningitis and encephalitis), heart inflammation or arthritis, are usually treated with a two-week course of intravenous ceftriaxone therapy. In most cases, timely diagnosis and prompt antibiotic treatment can improve symptoms.

But a misdiagnosis or late diagnosis can result in long-term illness, excessive use of antibiotic therapy, and expensive healthcare costs. Ignorance of the complex nature of this illness, especially the associated mental health issues, will further delay recovery. Dealing with these psychosocial problems regardless of whether they were triggered by Lyme bacteria or not can complement treatment and promote a quicker recovery.

Continued research and awareness about Lyme disease will be important for improving treatment and diagnosis. Developing more reliable diagnostic tests, identifying which patients are most likely to benefit from which antibiotic treatments, and taking measures to control tick populations will all be important for reducing instances of this disease in the future.

People can cut down on their risk of contracting Lyme disease by covering their skin in tall, grassy, wooded areas where disease-carrying ticks thrive. If you think youve been bitten by a tick, contact a doctor or health professional.

Excerpt from:
Lyme disease: Justin Bieber's tick-bite illness can cause joint pain, heart problems, and depression - The Conversation UK

Read More...

Cannabinoids in Medicine Part 3: Psoriasis and Rheumatoid Arthritis – Open Access Government

Friday, January 10th, 2020

Endocannabinoids, as well as several phytocannabinoids, have been shown to influence immune functions, regulating inflammation, autoimmunity, antitumourigenesis, antipathogenic responses and other processes.1 Numerous in vitro and in vivo studies have examined the therapeutic potential of cannabinoid signalling in inflammation-associated diseases (e.g. psoriasis) and attempted to dissect the complex immunological effects of cannabinoids.

Psoriasis is a chronic inflammatory disease of the skin, characterised by excessive proliferation of keratinocytes that results in the formation of thickened scaly plaques, itching and inflammatory changes of the epidermis and dermis.2 The underlying pathophysiology involves activation of classes of T-cells and their interaction with dendritic cells and other cells of the innate immune system, including neutrophils and keratinocytes.3

The following pre-clinical studies support the use of cannabinoids in the treatment of psoriasis:

A 2003 study in Journal of Clinical Investigation demonstrated that the cannabinoid receptors CB1 and CB2 are present in human skin cells, including keratinocytes;4

A 2003 study showed that anandamide, an endogenous CB receptor ligand, inhibits epidermal keratinocyte differentiation (abnormal keratinocyte differentiation is a hallmark of psoriasis);5

In 2004, a study in the Journal of Neuroimmunology used an in vivo mouse model to show that THC can shift the development of the predominantly pro-inflammatory T helper 1 (Th1) cell to the more anti-inflammatory (Th2) cell type profile;6

A 2007 study, published in the Journal of Dermatological Science, demonstrated that a range of cannabinoids inhibit keratinocyte proliferation in hyperproliferating human keratinocyte cell lines.7 The cannabinoids inhibited keratinocyte proliferation in a concentration-dependent manner. The activity of CBN (not significantly active at CB1/CB2 receptors) indicates more than one mechanism of action;

In 2011, a study using human cultured keratinocytes and a skin organotypic culture model, provided evidence that anandamide markedly suppresses keratinocyte proliferation and induces cell death, both in vitro and in situ. The cellular actions were mediated by CB1 and transient receptor potential vanilloid-1 (TRPV1). The cellular effects of anandamide are most probably mediated by Ca2+ influx and intracellular accumulation via the non-selective, highly Ca2+-permeable ion channel TRPV1. The study was published in the Journal of Investigative Dermatology;8

A 2016 study, published in the Annals of Dermatology, investigated the effect of CB1 agonists on mast cell activation. The authors found that CB1 agonists inhibited the release of inflammatory mediators and markedly and dose-dependently suppressed cell proliferation.9

RA is one of the most prevalent autoimmune diseases and one of the main causes of disability globally, causing pain, joint malformation and joint destruction.10 Preliminary evidence suggests that cannabinoids have a role in the future treatment of RA.

In one study,11 protein and mRNA expression of endocannabinoids, AEA and 2-AG, and cannabinoid receptors, CB1 and CB2, were found in synovial tissue obtained from 13 patients diagnosed with RA and undergoing arthroplasty whilst synovial tissue obtained from healthy volunteers was negative for the same endocannabinoids. Another study of synovial tissue from patients with RA12 found that of inflammatory cytokines, IL-6 and IL-8, which are stimulated by synovial cells, were attenuated by low concentrations of the synthetic cannabinoid WIN 55,212-2.

Furthermore, three different research groups achieved improvement in mice with collagen-induced arthritis (CIA), following treatment with various cannabinoids;13 The use of cannabinoids for the treatment of pain associated with RA has been assessed in only one 2006 clinical trial, where 58 patients with RA were allocated either nabiximols or a placebo.14 Compared with placebo, patients treated with nabiximols exhibited decreased pain along with improved sleep quality.15

1 Olh, A., et al. (2017) Targeting Cannabinoid Signalling in the Immune System: High-ly Exciting Questions, Possibilities, and Challenges. Front Immunol 8:1487.2 Habif, TP. (2016) Psoriasis and other papulosquamous diseases. Clinical Dermatology. 6th ed. Philadelphia, PA: Elsevier 263-328.3 van de Kerkhof, PCM and Nestl, FO (2018) Dermatology. 4th Edition, By Bolognia, JL., et al. 8, Psoriasis 138-160.4 Casanova, ML., et al. (2003) Inhibition of skin tumour growth and angiogenesis in-vivo by activation of cannabinoid receptors. J Clin Invest 111:43-50.5 Maccarrone, M., et al. (2003) The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem 278:33896-33903.6 Klein, TW., et al. (2004) Cannabinoid receptors and T helper cells. J Neuroimmunol 147:91-94.7 Wilkinson, JD., et al. (2007) Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatolog Sci 45:87-92.8 Tth, BI., et al. (2011) Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol 5:1095-104.9 Nam, G., et al. (2016) Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model. Ann Dermatol 28(1):22-9.10 Shapira, Y., et al. (2010) Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 6:468476.11 Richardson, D., et al. (2008) Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 10(2):R43.12 Lowin, T., et al. (2016) The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets. J Inflamm 13:15.13 Malfait, AM., et al. (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97:95619566; Fukuda, S., et al. (2014) Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. BMC Musculoskelet Disord 15:275; Gui, H., et al. (2015) Activation of cannabinoid receptor 2 attenuates synovitis and joint destruction in collagen-induced arthritis. Immunobiology 220:817822.14 Blake, DR., et al. (2006) Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 45:5052.15 Blake, DR., et al. (2006) Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology 45:5052.

*Please note: This is a commercial profile

Editor's Recommended Articles

Here is the original post:
Cannabinoids in Medicine Part 3: Psoriasis and Rheumatoid Arthritis - Open Access Government

Read More...

Chilled to the bone the link between cold weather and joint pain – StarNewsOnline.com

Friday, January 10th, 2020

By Max Shenin, DO

WednesdayJan8,2020at6:01AM

Editors Note: This article is made possible through a sponsored content partnership with New Hanover Regional Medical Center.

Chilled to the bone. Many of us have used this expression after spending some time outdoors in the cold weather. But it leads to perhaps one of the most common questions posed to all rheumatologists: Does the weather have any impact on our bones or joints? Many people are convinced that they are able to predict the weather based on increase in joint or back pain. A commonly quoted study conducted more than 10 years ago seemed to support this notion by showing that every 10-degree drop in temperature as well as a drop in barometric pressure can increase joint pain.

The Arthritis Foundation even provides an arthritis index on its website that is based on local temperature and barometric pressure that anyone can use if they chose. So mystery solved, right?

Not so fast. Like so many things in medicine, our knowledge is always evolving. One of the more recent and largest studies to date found absolutely no connection between changes in weather and joint pain. This conclusion was based on very comprehensive data collected from over 10 million doctor visits. And then there was another recent Dutch study that showed an increase in barometric pressure and humidity correlated well to increased joint pain, which directly contradicted the previous notion that the drop in barometric pressures was the culprit for your achy bones.

Digesting all of these conflicting findings can be a challenge for clinicians and patients alike. The reality is that the verdict is likely still out on this complex issue and there is more data to come. Until we get some more clarity, my recommendation is to go with whatever your body tells you. After all, no science can compete with personal experience that tells you that the ache you feel in your knees probably means that you should get your umbrella ready.

Dr. Max Shenin is a board-certified and fellowship trained rheumatologist with NHRMC Physician Group Rheumatology. To make an appointment, call 910.662.7550.

More here:
Chilled to the bone the link between cold weather and joint pain - StarNewsOnline.com

Read More...

CBD Technology and How CBD Patches Are Helping People – HealthTechZone

Friday, January 10th, 2020

Thanks to the advancement in technology, it seems like CBD is making its way into everything nowadays. The list of CBD-infused products includes intimate gels, sparkling water, chocolate, gummies, shampoo, skin creams, coffee, and so much more. One of the latest addition to the list is CBD patches.

As you probably already know, patches have been existing for many years already and are famous for effectively delivering healthy ingredients into the bloodstream. Today, its now getting utilized as a vehicle for CBD to get into your body and help you enjoy the benefits of the chemical.

The Technology Behind How CBD Patches Are Created

The technology used in creating CBD patches has already been around for decades, despite the product being relatively new in the market. The technological concept is much similar to birth control or nicotine patches, added with a couple of twists to ensure that the patch can deliver CBD to the bloodstream effectively.

CBD patches contain a dose of Cannabidiol molecules, infused in an isolated oil, gel, or solution. They also have carriers and permeation enhancers, and because your skin has a low CBD concentration, the high concentration of the patch moves the Cannabinoid into your body.

CBD patches and their transdermal application continue to become famous as an alternative way to reap all the benefits that CBD supplements bring to the table. Many people also view it as a way to receive a prolonged treatment dosage while being discreet.

Like any other CBD-infused products available in the market today, CBD patches cant get you high since Cannabidiol functions differently than THC, the psychoactive element of Cannabis plants. Accurate, useful, and comfortable, CBD patches are as simple as they sound, even if the technological process they undertake is a bit complicated.

This post will help you take a closer look at CBD patches, how these products work, and how they can help people.

Whats A CDB Patch And How Does The Product Work?

If you want to picture out what CBD patches look like, you only have to imagine large band-aids since theyre very closely similar in appearance. Also, like a large band-aid, you can peel and stick a CBD patch to any location in your body. The only difference is that the CBD patches are pieces of plastic infused with Cannabidiol.

Unlike the typical CBD oils, the patches arent wet. Theyre dry so they can stick to your skin. Most users place them on venous parts of the body, including their arms, ankles, and wrists. They do this since those areas have the potential for a higher absorption rate of CBD into the bloodstream.

Cannabidiol patches function by following a complex chemical reaction with the users body. Your body heat will activate the pieces and causes them to release CBD molecules and other ingredients that they contain. Please take note that in addition to Cannabidiol, some patches may contain caffeine, melatonin, THC, and more. Once these molecules get absorbed through the skin, they make their way into the bloodstream, where the body can start processing the compounds. After that, youll then begin to experience the benefits of CBD.

Benefits of CBD Patches

One of the essential benefits of CBD patches is the efficient delivery of Cannabinoid to the body. However, there are other equally important benefits, as well.

Here are some benefits of CBD patches:

1. Better Compound Absorption - Whats the reason behind CBD patches better absorption? It starts with the fact that your lungs and stomach are excellent at preventing any chemical from entering your bloodstream, which is how other CBD products, such as vape and gummies, enter. While its great that such a defense mechanism is possible to protect your body when youve inhaled or ingested something harmful, it also means that anything beneficial that youve consumed may reach your cells with limited effects.

By using CBD patches, you can bypass the filtering organs of your body, so more of the compound makes it into the bloodstream. It results in less CBD needed for you to feel and experience the benefits of the chemical.

2. Pain Management - CBD patches, like other CBD-infused products, have shown to alleviate ailments-related pains in the body, including lower back pains, spinal cord injury, arthritis, cancer, multiple sclerosis, muscle spasms, chemotherapy, and depression.

You can use CBD patches to manage both acute and chronic pains. Like band-aids, youll have to apply the patch to the site or area where you feel pain, allowing the supplement to get delivered immediately or over a short period.

Some CBD patches can also last for three days through nanotechnology in the reservoir patch, so its best to weigh your options based on your needs.

3. Arthritis - One of the leading causes of disability in the USA is arthritis. More than fifty-four million adults in the country have arthritis, which is more common in women than men. One type of arthritis, osteoarthritis, affects thirty-one million in the country by causing joints inflammation.

Several studies have pointed out the effectiveness of transdermal doses of CBD to reduce pain and other symptoms related to arthritis.

Final Thoughts

Many CBD users prefer transdermal delivery because it can bypass the stomach, liver, and lungs entirely - the traditional organs that break down or filter the Cannabinoid. So, such a method of taking Cannabidiol can give you at least fifty percent up to one hundred percent of the value of the supplement.

Kyle Tresch

Kyle Tresch is a pharmaceutical scientist who researches the efficacy of new drugs and medicines. Kyles responsibilities include discovering new compounds that can treat certain illnesses, development of these compounds to assess its safety and efficacy among human beings, and the manufacture of these compounds into drugs for public consumption.

Kyle shares his expertise by contributing articles to various platforms online.

Continue reading here:
CBD Technology and How CBD Patches Are Helping People - HealthTechZone

Read More...

Page 37«..1020..36373839..5060..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick